Measure the positive and negative syndromes of schizophrenia to develop treatment plans
The Positive and Negative Syndrome Scale (PANSS™) is based on findings that schizophrenia comprises at least two distinct syndromes: the positive syndrome, consisting of productive symptoms; and the negative syndrome, consisting of deficit features. It is useful when developing treatment plans because you can focus on the type of symptoms the patient is experiencing. The PANSS is also helpful when studying the effects of medication (e.g., in clinical drug trials) because it allows you to determine which type of symptoms are being affected.
Key Areas Measured
- Positive Scale
- Negative Scale
- General Psychopathology Scale
- Supplemental Aggression Risk Profile